Is Euromoney Institutional Investor plc a good investment in these troubled times?

The turnaround at Euromoney Institutional Investor plc (LON: ERM) looks like it’s coming good.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

We have a raft of publishing firms releasing results this month and next. Here are two different flavours for comparison and contrast.

Business information

Shares in Euromoney Institutional Investor (LSE: ERM) fell a couple of percent this morning, 1,028p, on the release of preliminary full-year results, although they actually looked quite reasonable and were pretty much in line with expectations.

Adjusted pre-tax profit fell by a modest 5%, to £102.5m with adjusted EPS down a similar proportion to 66.5p, and the firm maintained its full-year dividend at the expected 23.4p per share to yield 2.3% on the current share price.

The business and financial publisher and event organizer has suffered along with the rest of the print media business, as the idea of sending out information written on dead trees is really becoming old hat these days.

But according to chief executive Andrew Rashbass, the company’s recovery strategy, instigated in March is working, and he pointed to “the acceleration in subscription growth, which constituted a record 58% of our business in 2016, and in the flow of successful product launches” as examples of its success.

The firm is also changing direction through acquisition, having snapped up metals news and prices platform FastMarkets during the year, and Reinsurance Security, which rates reinsurance companies.

Euromoney shares are on a forward P/E, based on next year’s forecasts, of around 16 now, which is a bit above the FTSE average, and its dividend looks set to yield a below-average 2.3%. That, coupled with the decline of the print publishing business, might make the shares seem like a poor investment.

But it looks to me as if Euromoney is managing the shift to digital publishing and information provision competently, and the firm could well be at the bottom of a relatively modest downturn cycle with EPS growth on the cards again for 2017.

If that’s the case, we could be looking at a decent long-term investment here.

Traditional publishing

Turning to a more traditional publisher, shares in Daily Mail and General Trust (LSE: DMGT) have been under pressure since early 2014, but they’ve been staging a bit of a rally in the latter half of this year. The price took a dip immediately after the Brexit vote, but since a low on 6 July we’ve seen a 37% rise to today’s 790p.

A pre-close update in September helped, confirming that the group’s outlook remained in line with market expectations with underlying revenue growth of 4%.

The group continues to own 70% of Euromoney Institutional Investor, so the fortunes of the two companies are closely tied, with Euromoney’s revenues effectively contributing around 15% to Daily Mail’s returns on a revenue basis.

Full-year results should be with us on 1 December, and analysts are expecting them to show a fall in EPS of around 10%. But that would put the shares on a perfectly respectable P/E of 15 which would drop to under 14 if the predicted return to earnings growth for 2017 comes good.

Dividend yields are looking pretty average at around 3%, but the cash handout is growing and it should be more than twice covered by earnings.

It’s a sector not without risk, that’s for sure, but I see the recent share price recovery as being backed by sustainable earnings, and this is a share worth a closer look.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£10k in an ISA? I’d use it to aim for an annual £1k second income

Want a second income without having to take on a second job? With a bit of money up front, and…

Read more »

Investing Articles

Up over 100% in price in 10 years! Big Yellow also offers passive income from dividends

Oliver loves the look of Big Yellow to generate a healthy passive income from its generous dividends. He thinks storage…

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

If I put £750 into a SIPP every month, could I retire a millionaire?

Ben McPoland considers a high-quality FTSE 100 stock that could contribute towards building him a large SIPP portfolio in future.

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is Avon Protection the best stock to buy in the FTSE All-Share index right now?

Here’s a stock I’m holding for recovery and growth from the FTSE All-Share index. Can it be crowned as the…

Read more »

Investing Articles

Down 8.5% this month, is the Aviva share price too attractive to ignore?

It’s time to look into Aviva and the insurance sector while the share price is pulling back from year-to-date highs.

Read more »

Investing Articles

Here’s where I see Vodafone’s share price ending 2024

Valued at just twice its earnings, is the Vodafone share price a bargain or value trap? Our writer explores where…

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

The Darktrace share price jumped 20% today. Here’s why!

After the Darktrace share price leapt by a fifth in early trading, our writer explains why -- and what it…

Read more »

Dividend Shares

850 shares in this dividend giant could make me £1.1k in passive income

Jon Smith flags up one dividend stock for passive income that has outperformed its sector over the course of the…

Read more »